Johnson & Johnson (JNJ)

JNJ on New York Consolidated

100.21USD
20 Apr 2015
Change (% chg)

$0.63 (+0.63%)
Prev Close
$99.58
Open
$100.26
Day's High
$100.88
Day's Low
$100.05
Volume
6,668,541
Avg. Vol
9,162,794
52-wk High
$109.49
52-wk Low
$95.10

JNJ

Chart for JNJ

About

Johnson & Johnson is engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The business of Johnson & Johnson is conducted by more than 275 operating companies across the world. The Company’s primary focus has been on products related to human health and well-being.... (more)

Overall

Beta: 0.58
Market Cap(Mil.): $276,888.09
Shares Outstanding(Mil.): 2,780.56
Dividend: 0.70
Yield (%): 2.81

Financials

  JNJ Industry Sector
P/E (TTM): 17.83 40.59 41.17
EPS (TTM): 5.59 -- --
ROI: -- 16.74 16.08
ROE: -- 17.27 16.92
Search Stocks

BRIEF-Genmab reach $10 mln milestone in Johnson & Johnson collaboration

* Says achieves 10 million dollar milestone in daratumumab collaboration with Janssen, a pharmaceutical company of Johnson & Johnson

16 Apr 2015

Mining, utilities sink U.S. industrial production

WASHINGTON - U.S. industrial output posted its biggest drop in more than 2-1/2 years in March in part as oil and gas well drilling plummeted, highlighting the negative impact of lower crude prices and a strong dollar on the economy.

15 Apr 2015

WRAPUP 3-Mining, utilities sink U.S. industrial production

WASHINGTON, April 15 - U.S. industrial output posted its biggest drop in more than 2-1/2 years in March in part as oil and gas well drilling plummeted, highlighting the negative impact of lower crude prices and a strong dollar on the economy.

15 Apr 2015

Wall Street ends higher after bounce in oil prices

NEW YORK - The Dow and S&P 500 ended higher on Tuesday, helped by energy stocks and quarterly earnings reports that topped modest expectations following worries about a strong dollar.

14 Apr 2015

J&J cuts full-year forecast due to strong dollar

- Healthcare conglomerate Johnson & Johnson cut its full-year profit forecast on Tuesday, saying it expected a strong dollar to keep hurting its international business.

14 Apr 2015

UPDATE 2-J&J cuts full-year forecast due to strong dollar

* J&J expects to fend off Remicade biosimilar for nearly 3 years

14 Apr 2015

REFILE-US STOCKS-Wall St edges up after JPMorgan, J&J results

NEW YORK, April 14 - U.S. stocks rose modestly on Tuesday as investors digested the initial major earnings of the first-quarter reporting season, which showed some weakness despite companies topping lowered expectations.

14 Apr 2015

US STOCKS-Futures point to flat open after JPMorgan, J&J results

* Futures: Dow down 3 pts, S&P down 2 pts, Nasdaq up 1.5 pt (Updates with Wells results, retail sales data)

14 Apr 2015

J&J's first-qtr profit falls 8.6 pct

April 14 - Johnson & Johnson reported an 8.6 percent fall in quarterly profit as the impact of a strong dollar on overseas revenue offset growing sales of its mainstay older drugs.

14 Apr 2015

IBM launches new health unit, teams up with Apple, J&J, Medtronic

SEATTLE - International Business Machines Corp, deepening its partnership with Apple Inc to make use of health information gathered by millions of Apple devices, is creating a unit dedicated to providing data analytics to the healthcare sector.

13 Apr 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks